ResMed Inc. Files 8-K on Executive Changes and Shareholder Votes
Ticker: RSMDF · Form: 8-K · Filed: Nov 20, 2025 · CIK: 943819
| Field | Detail |
|---|---|
| Company | Resmed Inc (RSMDF) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.004 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, shareholder-vote
Related Tickers: RMD
TL;DR
ResMed filed an 8-K detailing executive changes, director elections, and shareholder votes.
AI Summary
ResMed Inc. filed an 8-K on November 20, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 9001 Spectrum Center Boulevard, San Diego, California.
Why It Matters
This filing provides updates on ResMed's corporate governance and executive team, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing standard business operations and governance changes.
Key Numbers
- 001-15317 — SEC File Number (Identifies the company's filing history with the SEC.)
- 98-0152841 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- RESMED INC (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 9001 Spectrum Center Boulevard, San Diego, California 92123 (address) — Principal Executive Offices
FAQ
What specific executive positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but does not specify the exact positions in the provided text.
Were there any significant shareholder votes or proposals mentioned in the filing?
Yes, the filing explicitly states 'Submission of Matters to a Vote of Security Holders' as an item covered.
What is the primary business of ResMed Inc. according to the SIC code?
The Standard Industrial Classification (SIC) code provided is 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 19, 2025.
What is the fiscal year end for ResMed Inc.?
ResMed Inc.'s fiscal year ends on June 30.
Filing Stats: 1,261 words · 5 min read · ~4 pages · Grade level 11.6 · Accepted 2025-11-20 16:30:26
Key Financial Figures
- $0.004 — ange on which registered Common Stock, $0.004 par value RMD NYSE Indicate by che
Filing Documents
- d74601d8k.htm (8-K) — 59KB
- 0001193125-25-289878.txt ( ) — 173KB
- rmd-20251119.xsd (EX-101.SCH) — 3KB
- rmd-20251119_lab.xml (EX-101.LAB) — 18KB
- rmd-20251119_pre.xml (EX-101.PRE) — 11KB
- d74601d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits Exhibits: Description of Document 10.1 The ResMed Inc. 2009 Incentive Award Plan, as amended and restated (incorporated by reference to Appendix A of ResMed Inc.'s Definitive Proxy Statement filed October 2, 2025). 10.2 The ResMed Inc. 2018 Employee Stock Purchase Plan, as amended and restated (incorporated by reference to Appendix B of ResMed Inc.'s Definitive Proxy Statement filed on October 2, 2025). 104 Cover Page Interactive Data File (embedded within the Inline XBRL, document).
SIGNATURES
SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. RESMED INC. Date: November 20, 2025 By: /s/ Michael Rider Michael Rider Chief Legal Officer, Global General Counsel and Secretary